Tsumura & Co
TSE:4540

Watchlist Manager
Tsumura & Co Logo
Tsumura & Co
TSE:4540
Watchlist
Price: 4 675 JPY -1.08%
Market Cap: 358.9B JPY
Have any thoughts about
Tsumura & Co?
Write Note

Tsumura & Co
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tsumura & Co
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Tsumura & Co
TSE:4540
Other Liabilities
ÂĄ8.8B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
0%
Takeda Pharmaceutical Co Ltd
TSE:4502
Other Liabilities
ÂĄ790.5B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
17%
Daiichi Sankyo Co Ltd
TSE:4568
Other Liabilities
ÂĄ917.9B
CAGR 3-Years
45%
CAGR 5-Years
31%
CAGR 10-Years
28%
Otsuka Holdings Co Ltd
TSE:4578
Other Liabilities
ÂĄ125.6B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
8%
Chugai Pharmaceutical Co Ltd
TSE:4519
Other Liabilities
ÂĄ13.4B
CAGR 3-Years
10%
CAGR 5-Years
-12%
CAGR 10-Years
-2%
Astellas Pharma Inc
TSE:4503
Other Liabilities
ÂĄ195.2B
CAGR 3-Years
38%
CAGR 5-Years
21%
CAGR 10-Years
16%
No Stocks Found

Tsumura & Co
Glance View

Market Cap
355B JPY
Industry
Pharmaceuticals

Tsumura & Co., a venerable name in the herbal medicine industry, traces its roots back to 1893. Emerging from Japan's rich pharmacopeia tradition, the company has carved a niche by blending age-old herbal knowledge with contemporary research and quality control. This synergy allows Tsumura to thrive in the modern marketplace, offering Kampo—a traditional Japanese herbal medicine—as their primary product line. Tsumura stands out in its meticulous approach to sourcing high-quality raw materials, employing state-of-the-art technology to ensure efficacy and safety. This rigorous quality assurance not only honors the integrity of traditional formulas but also aligns with the stringent standards of modern healthcare. In its pursuit of growth, Tsumura expertly navigates the delicate balance between tradition and innovation. The company generates revenue through the sale of its Kampo products, which are widely used in clinics and hospitals across Japan, reflecting a significant integration into the mainstream healthcare system. Additionally, Tsumura's strategic collaborations with pharmaceutical companies expand its reach into international markets. Through educational initiatives, they further advocate for the understanding and acceptance of herbal medicine globally. By continually investing in research and development, Tsumura aims to bolster their product offerings, ensuring that the ancient wisdom of Kampo remains relevant in today's fast-paced, health-conscious world.

Intrinsic Value
5 663.28 JPY
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Tsumura & Co's Other Liabilities?
Other Liabilities
8.8B JPY

Based on the financial report for Sep 30, 2024, Tsumura & Co's Other Liabilities amounts to 8.8B JPY.

What is Tsumura & Co's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
0%

Over the last year, the Other Liabilities growth was 2%. The average annual Other Liabilities growth rates for Tsumura & Co have been 8% over the past three years , 3% over the past five years .

Back to Top